About Elpis Biosciences

Built from a frustration I couldn't ignore.

My wife lives with chronic illness.

I've been fortunate — I've never dealt with serious illness myself. But I've watched her be dismissed by providers, talked over, told her symptoms aren't that bad. I've seen the gap between what science actually knows and what makes it into a doctor's office.

That frustration is where Elpis started.

I'm a bioinformatics researcher. I build tools that process biological data — fast, open-source tools for phylogenetics and genomics. I'm not a geneticist or a clinician. But I know how to find published research, evaluate the evidence, and present it in a way that's honest and accessible.

When I looked at what was available for people who already have genetic data from 23andMe or AncestryDNA, I found two things: expensive reinterpretation services that charge for what amounts to a text file lookup, and wellness companies that wrap weak evidence in flowery language to sell supplements.

"People need someone to sit down, look at the actual published studies, and say: here's what the research found, here's how strong the evidence is, here's what it can and cannot tell you, and here are the questions to bring to your doctor. That's what Elpis does. Nothing more, nothing less."
Andrew Budge
Andrew Budge
Founder · Bioinformatics Researcher

Bioinformatics researcher at Utah Valley University. Builds open-source tools for phylogenetics and genomics (Cladekit, Liger, SeqRipper). Developing Elpis as a bridge between published genetic research and the people it's about.

Our values

It's not our data. It's yours.
We don't own your genetic information. We don't store it. We don't sell it. We don't even see it. We're honored that you trust us to help you understand it.
Genetics is one layer.
Your genes don't consign you to a fate. They're one factor in the multifaceted picture of health. We report what the research says — not what will happen to you.
Honesty over comfort.
We'd rather tell you we don't know something than pretend we do. If the evidence is thin, we say so. If a variant isn't on your chip, we say so. If the studies only included one population, we say so.
Access over profit.
Free reports, always. No paywalls. No subscriptions. No "premium insights." When we charge for something in the future, it will be for things that actually cost money to produce.

What we are not

We are not a wellness company. We are not a diagnostics company — yet. We are not in the business of selling supplements based on your genotype or giving you a score that makes you feel optimized.

We watched what happened to 23andMe. The technology was genuinely impressive. The failure was in treating user data as an asset rather than a trust. Elpis is built against that from the ground up.